Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Guadecitabine sodium by Astex Pharmaceuticals for Chondrosarcoma: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Chondrosarcoma. According to GlobalData, Phase...
Guadecitabine sodium by Astex Pharmaceuticals for Non-Small Cell Lung Cancer: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Non-Small Cell Lung Cancer. According...
Guadecitabine sodium by Astex Pharmaceuticals for Small-Cell Lung Cancer: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Small-Cell Lung Cancer. According to...
Guadecitabine sodium by Astex Pharmaceuticals for T-Cell Lymphomas: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for T-Cell Lymphomas. According to GlobalData,...
Onalespib by Astex Pharmaceuticals for Mantle Cell Lymphoma: Likelihood of Approval
Onalespib is under clinical development by Astex Pharmaceuticals and currently in Phase II for Mantle Cell Lymphoma. According to GlobalData,...
Guadecitabine sodium by Astex Pharmaceuticals for Non-Hodgkin Lymphoma: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Non-Hodgkin Lymphoma. According to GlobalData,...
Guadecitabine sodium by Astex Pharmaceuticals for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Peripheral T-Cell Lymphomas (PTCL). According...
Guadecitabine sodium by Astex Pharmaceuticals for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy....
Guadecitabine sodium by Astex Pharmaceuticals for Cutaneous T-Cell Lymphoma: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Cutaneous T-Cell Lymphoma. According to...
Guadecitabine sodium by Astex Pharmaceuticals for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL)....
Guadecitabine sodium by Astex Pharmaceuticals for Small-Cell Lung Cancer: Likelihood of Approval
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Small-Cell Lung Cancer. According to...